Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 10:9:624.
doi: 10.3389/fgene.2018.00624. eCollection 2018.

A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases

Serena Oliveri  1   2 , Federica Ferrari  2 , Andrea Manfrinati  2 , Gabriella Pravettoni  1   2
Affiliations
Review

A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases

Serena Oliveri et al. Front Genet. .

Abstract

Background: Genetic testing is performed for different purposes, such as identifying carriers, predicting a disease onset in presymptomatic individuals or confirming a diagnosis. However, these tests may have notable psychological effects, such as generating anxiety and depression. These effects may depend on people's perception of risk, severity, and controllability of the disease; and the availability of treatments. To date, there are no reports that analyze these factors specifically, and their role in influencing genetic test users' experience. Methods: We performed a systematic review of the psychological implication of undergoing genetic testing for cardiovascular, neurodegenerative and cancer diseases. Articles were searched on PubMed, Google Scholar, and PsychInfo. Results: 47 studies were included, 9 concerning cardiovascular disease, 18 neurodegenerative disorders, and 20 for cancer disease. According to the reviewed studies, people experience no significant increase in distress and anxiety, or adverse impacts on quality of life, except the Huntington disease, which is characterized by depressive symptoms, suicidal ideations, and hopelessness in gene carriers. People tend to consider genetic tests as valid information to take important preventive decisions. Genetic risk for cardiovascular disease is perceived to be manageable; genetic analysis for some neurodegenerative diseases (e.g., Alzheimer) or cancer (breast cancer in particular) is considered useful because the problem could be addressed in advance with preventive behaviors. Conclusions: Genetic tests should be proposed along with proper psychological support and counseling focused on users' genetic health literacy; perception of risk, beliefs about disease controllability, in order to foster fruitful medical decisions.

Keywords: chronic disease; genetic risk; genetic testing; health psychology; psychological implication; quality of life.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram describing the study selection.
See this image and copyright information in PMC

References

    1. Abegunde D. O., Mathers C. D., Adam T., Ortegon M., Strong K. (2007). The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370, 1929–1938. 10.1016/S0140-6736(07)61696-1 - DOI - PubMed
    1. Almqvist E. W., Brinkman R. R., Wiggins S., Hayden M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin. Genet. 64, 300–309. 10.1034/j.1399-0004.2003.00157.x - DOI - PubMed
    1. Andrews L., Meiser B., Apicella C., Tucker K. (2004). Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet. Test. 8, 240–247. 10.1089/gte.2004.8.240 - DOI - PubMed
    1. Arver B., Haegermark A., Platten U., Lindblom A., Brandberg Y. (2004). Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam. Cancer 3, 109–116. 10.1023/B:FAME.0000039863.89137.f9 - DOI - PubMed
    1. Aspinwall L. G., Taber J. M., Leaf S. L., Kohlmann W., Leachman S. A. (2013). Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome. Psychooncology. 22, 276–289. 10.1002/pon.2080 - DOI - PubMed

LinkOut - more resources